Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.biomaterials.2007.01.002
Title: In vitro biocompatibility and bioactivity of microencapsulated heparan sulfate
Authors: Luong-Van, E.
Nurcombe, V. 
Cool, S. 
Grondahl, L.
Keywords: Bone repair
Drug delivery
Heparan sulfate
Microencapsulation
Polycaprolactone
Issue Date: 2007
Source: Luong-Van, E., Nurcombe, V., Cool, S., Grondahl, L. (2007). In vitro biocompatibility and bioactivity of microencapsulated heparan sulfate. Biomaterials 28 (12) : 2127-2136. ScholarBank@NUS Repository. https://doi.org/10.1016/j.biomaterials.2007.01.002
Abstract: The glycosaminoglycan sugar heparan sulfate (HS) is an attractive agent for the repair of bone defects due to its ability to regulate endogenous growth factors. The sustained delivery of HS to the localized wound site over the period of healing which can last for over 1 month may prove advantageous for its therapeutic use. In this study we investigated the encapsulation of HS by the water-in oil-in water (W1/O/W2) technique in polycaprolactone (PCL) microcapsules as a prolonged delivery device. Encapsulation efficiencies of 70% could be achieved by using a 1:1 mixture of dichloromethane (DCM) and acetone as the solvent in the organic phase, while DCM alone gave poor encapsulation. Although addition of polyvinyl alcohol (PVA) to the drug phase did not affect the size or drug loading of the microcapsules, it did however produce a large change in the morphology and drug distribution, which resulted in different release rates. Release from capsules made with PVA in the drug phase reached 60% after 40 days, while those made with water in the drug phase completed release after 20 days. In vitro biocompatibility studies were performed and detected no increase in cell death in human mesenchymal stem cells (hMSC) or induction of an inflammatory response in macrophages after exposure to release products from HS-loaded microcapsules. The released HS retained its ability to increase the proliferation of hMSC after the encapsulation process. These results indicate that encapsulation of HS by the W1/O/W2 method creates a promising device for the repair of bone tissue. © 2007 Elsevier Ltd. All rights reserved.
Source Title: Biomaterials
URI: http://scholarbank.nus.edu.sg/handle/10635/25282
ISSN: 01429612
DOI: 10.1016/j.biomaterials.2007.01.002
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

20
checked on Dec 7, 2017

WEB OF SCIENCETM
Citations

17
checked on Nov 23, 2017

Page view(s)

138
checked on Dec 11, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.